Melatonin multifaceted pharmacological actions on melatonin receptors converging to abrogate COVID‐19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Melatonin multifaceted pharmacological actions on melatonin receptors converging to abrogate COVID‐19

Published:2021-04-26 Issue: Volume: Page:
ISSN:0742-3098
Container-title:Journal of Pineal Research
language:en
Short-container-title:J Pineal Res

Author:

Reynolds Jessica L.¹,Dubocovich Margarita L.²³^ORCID

Affiliation:

1. Department of Medicine Jacobs School of Medicine and Biomedical Sciences University at Buffalo Buffalo NY USA

2. Department of Pharmacology and Toxicology Jacobs School of Medicine and Biomedical Sciences University at Buffalo Buffalo NY USA

3. Interdepartmental Graduate Program in Neuroscience Jacobs School of Medicine and Biomedical Sciences University at Buffalo Buffalo NY USA

Publisher

Wiley

Subject

Endocrinology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jpi.12732

Reference19 articles.

1. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

2. A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

3. A Review of the Multiple Actions of Melatonin on the Immune System

4. Melatonin as a chronobiotic

5. MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melatonin Rescues Influenza A Virus–Induced Cellular Energy Exhaustion via OMA1‐OPA1‐S in Acute Exacerbation of COPD;Journal of Pineal Research;2024-07-22

2. Melatonin and Cytokines Modulate Daily Instrumental Activities of Elderly People with SARS-CoV-2 Infection;International Journal of Molecular Sciences;2023-05-12

3. Development of indolealkylamine derivatives as potential multi-target agents for COVID-19 treatment;European Journal of Medicinal Chemistry;2023-03

4. Therapeutic Benefits of Melatonin against COVID-19;Neuroimmunomodulation;2023

5. Melatonin’s Benefits as a Treatment for COVID-19 Pandemic and Long COVID;COVID-19 and Sleep: A Global Outlook;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3